Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Neutropenia 1Neoplasms 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

venetoclax 72Specimen Handling 69Cyclophosphamide 60Cytarabine 53Biopsy 51fludarabine 46Azacitidine 35Rituximab 26blinatumomab 24fludarabine phosphate 22Methotrexate 22Daunorubicin 22Magnetic Resonance Spectroscopy 21Vincristine 19Prednisone 17Dexamethasone 17Whole-Body Irradiation 16Melphalan 16Injections 16Busulfan 16ibrutinib 15decitabine and cedazuridine drug combination 15Granulocyte Colony-Stimulating Factor 15merphos 14Tacrolimus 14Mycophenolic Acid 14Doxorubicin 14acalabrutinib 13obinutuzumab 12Stem Cell Transplantation 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cefepime × Other hematologic neoplasm × 30 days × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡